Site icon OncologyTube

Personalizing lung cancer therapy in the era of next generation sequencing, targeted therapies, and emerging immunotherapies.

Edward B. Garon, MD, MS, Director of Thoracic Oncology, David Geffen School of Medicine at UCLA discusses Personalizing lung cancer therapy in the era of next generation sequencing, targeted therapies, and emerging immunotherapies at the MOASC Oncology Summit

Exit mobile version